Inventor
LEE MATTHEW RANDOLPH
US10 patents
⚠️ This page may combine multiple inventors who share the name “LEE MATTHEW RANDOLPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MIRATI THERAPEUTICS INC
7 patentsUS11267812B2Mar 8, 2022
KRAS G12C inhibitors
MIRATI THERAPEUTICS INC11 citations84
US11091495B2Aug 17, 2021
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC4 citations82
US11932633B2Mar 19, 2024
KRas G12C inhibitors
MIRATI THERAPEUTICS INC2 citations71
US11220509B2Jan 11, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC2 citations71
US10266542B2Apr 23, 2019
EZH2 inhibitors
MIRATI THERAPEUTICS INC6 citations67
US12371435B2Jul 29, 2025
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61
US11485738B2Nov 1, 2022
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
MIRATI THERAPEUTICS INC0 citations61
Cervello Therapeutics LLC
3 patentsUS11912719B2Feb 27, 2024
Substituted isoquinolines as rock kinase inhibitors
Cervello Therapeutics LLC0 citations54
US11248004B2Feb 15, 2022
Substituted isoquinolines as rock kinase inhibitors
Cervello Therapeutics LLC0 citations54
US10745381B2Aug 18, 2020
Substituted isoquinolines and phthalazines as rock kinase inhibitors
Cervello Therapeutics LLC0 citations42